Embark Biotech

Copenhagen, Denmark

Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.

$1.6M raised

Sep 2021

Convertible Note

Biotechnology Life Science Medical

Top Investors

BioInnovation Institute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Embark Biotech

How much funding has Embark Biotech raised?

Embark Biotech has raised $1.6M in total funding. The most recent round was Convertible Note. The last funding was announced in September 2021.

Who are Embark Biotech's investors?

Embark Biotech's investors include BioInnovation Institute.

Where is Embark Biotech headquartered?

Embark Biotech is headquartered in Copenhagen, Denmark.

What does Embark Biotech do?

Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.

What stage is Embark Biotech at?

Embark Biotech is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 23, 2021.

MLA

"Embark Biotech — Funding & Investors." VCBacked, September 23, 2021, https://www.vcbacked.co/company/embark-biotech. Accessed July 2, 2026.

APA

VCBacked. (2021). Embark Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/embark-biotech

Wikipedia (cite web)

{{cite web |title=Embark Biotech — Funding & Investors |url=https://www.vcbacked.co/company/embark-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 23, 2021.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K